Lamarre J, Vasudevan J, Gonias S L
Department of Biomedical Sciences, University of Guelph, Ontario, Canada.
Biochem J. 1994 Aug 15;302 ( Pt 1)(Pt 1):199-205. doi: 10.1042/bj3020199.
Plasmin regulates the activity and distribution of transforming growth factor beta (TGF-beta) and other growth factors. The purpose of the present investigation was to determine the effects of plasmin on cellular receptors for TGF-beta. AKR-2B fibroblasts were affinity-labelled with 125I-TGF-beta 1 and 125I-TGF-beta 2, demonstrating betaglycan, the type-I TGF-beta receptor and the type-II TGF-beta receptor. Treatment of TGF-beta-affinity-labelled cells with plasmin (10-100 nM) for 1 h profoundly and selectively decreased recovery of TGF-beta-betaglycan complex. The type-I and type-II receptors were not plasmin substrates. A radiolabelled complex with an apparent mass of 60 kDa was detected by SDS/PAGE in both the medium and cell extracts of plasmin-treated affinity-labelled cells. In order to demonstrate that plasmin cleavage of betaglycan did not require prior exposure of the betaglycan to cross-linking agent, AKR-2B cells were treated with plasmin first and then affinity-labelled. Markedly decreased TGF-beta binding to cellular betaglycan was observed. Although plasmin treatment of AKR-2B cells decreased overall binding of 125I-TGF-beta 1 and 125I-TGF-beta 2, the rate at which the cells degraded bound 125I-TGF-beta at 37 degrees C was not changed. AKR-2B cells treated with plasmin demonstrated slightly increased [3H]thymidine incorporation; the plasmin-treated cells retained their ability to respond to TGF-beta. Conditioned medium from plasmin-treated AKR-2B cells contained increased amounts of active TGF-beta as determined in Mv 1 Lu epithelial-cell-proliferation assays. Specific cleavage of betaglycan represents a novel mechanism whereby plasmin may regulate the assortment of receptors available for TGF-beta. In addition, plasmin may facilitate transfer of active TGF-beta between neighbouring cells by releasing the active growth factor from the cell surface.
纤溶酶调节转化生长因子β(TGF-β)及其他生长因子的活性和分布。本研究的目的是确定纤溶酶对TGF-β细胞受体的影响。用¹²⁵I-TGF-β1和¹²⁵I-TGF-β2对AKR-2B成纤维细胞进行亲和标记,证实了β聚糖、I型TGF-β受体和II型TGF-β受体的存在。用纤溶酶(10 - 100 nM)处理TGF-β亲和标记的细胞1小时,可显著且选择性地降低TGF-β - β聚糖复合物的回收率。I型和II型受体不是纤溶酶的作用底物。在纤溶酶处理的亲和标记细胞的培养基和细胞提取物中,通过SDS/聚丙烯酰胺凝胶电泳检测到一种表观质量为60 kDa的放射性标记复合物。为了证明纤溶酶对β聚糖的切割不需要β聚糖预先暴露于交联剂,先对AKR-2B细胞用纤溶酶处理,然后进行亲和标记。观察到TGF-β与细胞β聚糖的结合明显减少。虽然用纤溶酶处理AKR-2B细胞会降低¹²⁵I-TGF-β1和¹²⁵I-TGF-β2的总体结合,但细胞在37℃降解结合的¹²⁵I-TGF-β的速率并未改变。用纤溶酶处理的AKR-2B细胞显示[³H]胸苷掺入略有增加;经纤溶酶处理的细胞保留了对TGF-β作出反应的能力。在Mv 1 Lu上皮细胞增殖试验中测定,来自纤溶酶处理的AKR-2B细胞的条件培养基中活性TGF-β的含量增加。β聚糖的特异性切割代表了一种新机制,通过该机制纤溶酶可能调节TGF-β可用受体的种类。此外,纤溶酶可能通过从细胞表面释放活性生长因子来促进活性TGF-β在相邻细胞之间的转移。